Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma

Journal of Surgical Oncology

Volumn 102, Issue 6, 2010, Pages 683-688

  Liu, Hong Tao ^a   Wang, Ning ^b   Wang, Xin ^c   Li, Sheng Lei ^c  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Province Chinese Medicine Research Institute   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

esophageal squamous cell carcinoma; immunohistochemistry; in situ hybridization; prognosis; provirus integration site for Moloney murine leukemia virus 1

Indexed keywords

MESSENGER RNA; PROTEIN KINASE PIM 1;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-PIM-1; TUMOR MARKERS, BIOLOGICAL;

EID: 78349301133     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21627     Document Type: Article

References (35)

1. Iwanski GB, Block A, Keller G, et al.: Esophageal squamous cell carcinoma presenting with extensive skin lesions: A case report. J Med Case Rep 2008; 2: 115.
2. Pisani P, Parkin DM, Bray F, et al.: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29. (Pubitemid 29409471)
3. Kelsen DP, Ginsberg R, Pajak TF, et al.: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984.
4. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167.
5. Enzinger PC, Mayer RJ,: Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
6. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
7. Shimada H, Nabeya Y, Okazumi S, et al.: Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 2003; 133: 486-494. (Pubitemid 36638220)
8. Cuypers HT, Selten G, Quint W, et al.: Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region. Cell 1984; 37: 141-150.
9. van der Lugt NM, Domen J, Verhoeven E, et al.: Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J 1995; 14: 2536-2544.
10. Muraski JA, Rota M, Misao Y, et al.: Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 2007; 13: 1467-1475.
11. Zemskova M, Sahakian E, Bashkirova S, et al.: The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. J Biol Chem 2008; 283: 20635-20644.
12. Zhao Y, Hamza MS, Leong HS, et al.: Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells. Oncogene 2008; 27: 1-8.
13. Chen LS, Redkar S, Bearss D, et al.: Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. Blood 2009; 114: 4150-4157.
14. Chen J, Kobayashi M, Darmanin S, et al.: Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am J Pathol 2009; 175: 400-411.
15. Chen J, Kobayashi M, Darmanin S, et al.: Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene 2009; 28: 2581-2592.
16. Shah N, Pang B, Yeoh KG, et al.: Potential roles for the PIM1 kinase in human cancer-A molecular and therapeutic appraisal. Eur J Cancer 2008; 44: 2144-2151.
17. Reiser-Erkan C, Erkan M, Pan Z, et al.: Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 2008; 7: 1352-1359.
18. Warnecke-Eberz U, Bollschweiler E, Drebber U, et al.: Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases. Oncol Rep 2008; 20: 619-624.
19. Warnecke-Eberz U, Bollschweiler E, Drebber U, et al.: Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer. Anticancer Res 2009; 29: 4451-4455.
20. Hezel AF, Bardeesy N,: Prognostic markers in pancreatic ductal adenocarcinomas. Cancer Biol Ther 2008; 7: 1360-1361.
21. Lloyd RV, Vidal S, Jin L, et al.: Myosin XVA expression in the pituitary and in other neuroendocrine tissues and tumors. Am J Pathol 2001; 159: 1375-1382.
22. Li S, Jiao J, Lu Z, et al.: An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells. Oncol Rep 2009; 21: 1223-1233.
23. Meeker TC, Nagarajan L, ar-Rushdi A, et al.: Characterization of the human PIM-1 gene: A putative proto-oncogene coding for a tissue specific member of the protein kinase family. Oncogene Res 1987; 1: 87-101.
24. Cibull TL, Jones TD, Li L, et al.: Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol 2006; 59: 285-288.
25. Choi JY, Cho SI, Do NY, et al.: Clinical significance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg 2010; 39: 28-34.
26. Beier UH, Weise JB, Laudien M, et al.: Overexpression of Pim-1 in head and neck squamous cell carcinomas. Int J Oncol 2007; 30: 1381-1387.
27. Lilly M, Sandholm J, Cooper JJ, et al.: The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999; 18: 4022-4031.
28. Leduc I, Karsunky H, Mathieu N, et al.: The Pim-1 kinase stimulates maturation of TCRbeta-deficient T cell progenitors: Implications for the mechanism of Pim-1 action. Int Immunol 2000; 12: 1389-1396.
29. Roh M, Gary B, Song C, et al.: Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res 2003; 63: 8079-8084.
30. Ellwood-Yen K, Graeber TG, Wongvipat J, et al.: Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003; 4: 223-238.
31. Valdman A, Fang X, Pang ST, et al.: Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate 2004; 60: 367-371.
32. Roder JD, Stein HJ, Siewert JR,: Oesophageal carcinoma. In:, Hermaneck P, Gospodarowicz MK, Henson DE, et al.: editors. Prognostic factors in cancer, UICC. Berlin, Germany: Springer-Verlag; 1995. pp 37-46.
33. Wang DY, Xiang YY, Tanaka M, et al.: High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 1994; 74: 3089-3096.
34. Yoshida K, Kawami H, Yamaguchi Y, et al.: Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene. Cancer 1995; 75: 1467-1471.
35. Ikeda G, Isaji S, Chandra B, et al.: Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 1999; 86: 1396-1405.